ROCKVILLE, MD — April 13 2021 — Psomagen, Inc., a US-based genetic sequencing and data analysis service provider, is collaborating with Swift Biosciences (now part of Integrated DNA Technologies), a pioneer in the development of research-use-only library preparation kits, to offer comprehensive SARS-CoV-2 variant determination using next-generation sequencing (NGS). Early in the pandemic, public health […]
As one of the newest members of the COVID-19 Testing Industry Consortium, we wanted to share with you the results of our Back-to-Work survey. The survey, conducted last fall, represents the experiences of 77 organizations across the United States. We hope the information inside will help us understand the intricacies of the ongoing pandemic challenges […]
The new strain of coronavirus known as SARS-CoV-2 or COVID-19 is a highly contagious yet highly selective respiratory virus that continues to puzzle researchers and medical professionals. At first, it seemed as though only the elderly and those with underlying health conditions were at risk of developing severe symptoms and dying from the virus — […]
To the knowledge of scientists and the CDC, the family of coronaviruses has been around since the mid-1960s. One of the most deadly of these viruses came about in the early 2000s when Severe Acute Respiratory Syndrome, otherwise known as SARS, emerged in China. A decade later, the Middle East Respiratory Syndrome (MERS) developed in […]
Psomagen, Inc. (previously Macrogen Corp.), established in 2004, offers “total genomic solutions” for both clinical and research purposes, mainly focusing on end-to-end sequencing services. The company will expand its services to include personal DNA tests.